BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 26306845)

  • 1. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
    Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
    Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
    Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
    Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
    Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
    Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate.
    Macedo LB; Nogueira-Librelotto DR; de Vargas J; Scheeren LE; Vinardell MP; Rolim CMB
    AAPS PharmSciTech; 2019 Apr; 20(5):165. PubMed ID: 30993464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.
    Wang J; Zhang Z; Ai Y; Liu F; Chen MM; Liu D
    Carbohydr Res; 2021 Mar; 501():108275. PubMed ID: 33657498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
    Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
    Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
    Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
    AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
    Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
    Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
    Li S; Xiong Y; Zhang X
    Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
    Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
    Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Sensitive chitosan-tripolyphosphate nanoparticles increase doxorubicin-induced growth inhibition of cervical HeLa tumor cells by apoptosis and cell cycle modulation.
    Nogueira-Librelotto DR; Scheeren LE; Macedo LB; Vinardell MP; Rolim CMB
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110897. PubMed ID: 32126359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
    Fathi M; Barar J; Erfan-Niya H; Omidi Y
    Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate loaded on magnetite iron nanoparticles coated with chitosan: Biosynthesis, characterization, and impact on human breast cancer MCF-7 cell line.
    Ali EMM; Elashkar AA; El-Kassas HY; Salim EI
    Int J Biol Macromol; 2018 Dec; 120(Pt A):1170-1180. PubMed ID: 30172815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
    Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
    Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
    Jeevitha D; Amarnath K
    Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
    Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.